Robert F. Kennedy, Jr., the Secretary of Health and Human Services, told Congress that he has directed the Food and Medicines Administration to review the regulations of the Mifepristone abortion pill, resenting reproductive rights after he cited an insufficient study of the widely used drugs.
“I asked Marty Makari, who is the director of the FDA, to do a full review and report back,” said Kennedy, a notorious skeptic and conspiracy theorist on vaccines and other public health issues, about listening to the Senate budget on Wednesday.
Makari is a former Fox News presenter known for claiming on national television that the fetus can “resist” abortion.
Kennedy confirmed that any drug decision will be informed by a deeply insufficient report published last month by conservative cerebral trust, although experts say the so-called study has a clear conflict of interest and has not been examined by the renewal of a man-by-a-do-up exam Center.
Robert F. Kennedy, Jr., testifies during a hearing on Wednesday before hearing the house budget. Anadolu by Getty Images
Health Secretary has continued to say that the new report, which claims, that 11% of Mifepristone users “experience sepsis, infection, bleeding” after its acceptance is “anxious” and “clearly shows that in [the] At least, the label must be changed. “
In addition to not reviewing, the report does not include its set of data and codes of the procedures, something that scientists told Huffpost last month is both unusual and makes it impossible for the other researchers to fully evaluate its methodology and the integrity of the report results.
Kennedy’s remarks were in response to questions from Senator Josh Hooley (R-Mo.), Which led the current fee to break down on Mifepristone. He celebrates Kennedy’s response on social media.
“It’s a lifelong win,” he said, sharing a video of their exchange.
Defenders of reproductive rights and experts say they are deeply concerned about Kennedy’s comments.
“It is clear that our rights are attacked. The outrageous proposal of RFK JR. that President Trump can decide whether people can have access to abortion medicines is only the beginning,” Alexis McGil Johnson, President and Executive Director of the Planned Parental Action Fund, said that the report is saying that the report is saying that the report.
Decades of MifePristone study have produced numerous reviews that have proven that Mifepristone is extremely safe and effective. Used in 63% of all abortions, the Gutmacher Institute opened last year, which is a remarkable 10% since 2020.
An abortion activist holds a box of Mifepristone pills during a demonstration outside the Supreme Court in March 2024. By Associated Press
“Mifepriston, like any other medicine prescribed in the United States, goes through a strict approval process, prioritizing the safety and efficacy of drugs,” says Ashley Jeanlus, Ob-Gyn and an associate with reproductive health doctors.
“Due to the stigma that they take care of abortions in this country, thanks to politicians and employees against abortion, such as those who discuss fake reports today, Mifepristone has suffered even further control than other drugs,” she continued. “As an abortion supplier, I know that attacks against Mifepristone are attacks on the health and autonomy of patients I care every day.”
Kennedy’s comments on Wednesday are in accordance with what he said during his hearing to confirm in January: that President Donald Trump has directed him to study the safety of Mifepriston.
“President Trump asked me to study the safety of Mifepristone,” he said. “He still hasn’t dealt with how to regulate him. Whatever he does, I will implement these policies.”
Although the Kennedy Directive represents health effects for millions of people, he admitted to hearing on Wednesday that he is not an expert.
“I don’t think people should take medical advice from me,” he said three days after advertising that he was swimming in a sewer creek with his grandchildren.